Aberdeen Group
TCRX icon

Aberdeen Group’s TScan Therapeutics TCRX Stock Holding History

Aberdeen Group’s Portfolio TCRX Stock Details TCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$927K Sell
918,020
-867,221
-49% -$927K ﹤0.01% 829
2025
Q4 		$1.79M Buy
1,785,241
+430,421
+32% +$623K ﹤0.01% 787
2025
Q3 		$2.47M Buy
1,354,820
+463,372
+52% +$821K ﹤0.01% 763
2025
Q2 		$1.29M Hold
891,448
– – ﹤0.01% 810
2025
Q1 		$1.23M Buy
891,448
+7,744
+0.9% +$16.8K ﹤0.01% 800
2024
Q4 		$2.69M Buy
883,704
+512,049
+138% +$2.32M 0.01% 729
2024
Q3 		$1.85M Buy
371,655
+79,511
+27% +$480K ﹤0.01% 760
2024
Q2 		$1.71M Buy
292,144
+92,144
+46% +$726K ﹤0.01% 769
2024
Q1 		$1.59M Hold
200,000
– – ﹤0.01% 793
2023
Q4 		$1.17M Buy
+200,000
New +$916K ﹤0.01% 825

Other funds holding TCRX

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return